Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MRAS |
| Upstream (Parents) |
|---|
| (<<) ATP7B → MRAS |
| (<<) BMP2 → MRAS |
| (<<) BZW1 → MRAS |
| (<<) CD83 → MRAS |
| (<<) CMTM7 → MRAS |
| (<<) ELF5 → MRAS |
| (<<) ERBB2 → MRAS |
| (<<) GPX4 → MRAS |
| (<<) GRK5 → MRAS |
| (<<) LOC650392 → MRAS |
| (<<) LRP6 → MRAS |
| (<<) LYPLA2 → MRAS |
| (<<) MLPH → MRAS |
| (<<) PTGS2 → MRAS |
| (<<) RAB5B → MRAS |
| (<<) SERPINB5 → MRAS |
| (<<) SH3KBP1 → MRAS |
| (<<) SPDEF → MRAS |
| (<<) TCF7L1 → MRAS |
| (<<) TMEM45B → MRAS |
| (<<) VAV3 → MRAS |
| Downstream (Children) |
|---|
| MRAS → ADCY3 (>>) |
| MRAS → ARL4C (>>) |
| MRAS → BRCA1 (>>) |
| MRAS → CRYAB (>>) |
| MRAS → CXCL3 (>>) |
| MRAS → DEPDC7 (>>) |
| MRAS → DUSP10 (>>) |
| MRAS → FAM83A (>>) |
| MRAS → FGFR2 (>>) |
| MRAS → KCNJ2 (>>) |
| MRAS → KLF11 (>>) |
| MRAS → KRT6B (>>) |
| MRAS → MBOAT2 (>>) |
| MRAS → MREG (>>) |
| MRAS → NCOA7 (>>) |
| MRAS → NFATC1 (>>) |
| MRAS → NFIB (>>) |
| MRAS → NOTCH1 (>>) |
| MRAS → NPAS3 (>>) |
| MRAS → PIK3CB (>>) |
| MRAS → PODXL (>>) |
| MRAS → SAA4 (>>) |
| MRAS → SLC5A1 (>>) |
| MRAS → SOCS5 (>>) |
| MRAS → ST3GAL6 (>>) |
| MRAS → SULT2B1 (>>) |
| MRAS → TARSL2 (>>) |
| MRAS → TMEM158 (>>) |
| MRAS → TNFRSF11A (>>) |
| MRAS → TRIB3 (>>) |
| MRAS → UBE2E3 (>>) |
| MRAS → WWTR1 (>>) |
